2008/522/EC: Decision of the European Parliament of 24 April 2007 on closing the accounts of the European Medicines Agency for the financial year 2005
Date: 2008-04-24
Institutions: European Parliament
Subjects: European Medicines Agency, closing of accounts, financial year, implementation of the budget

15.7.2008

EN

Official Journal of the European Union

L 187/133

DECISION OF THE EUROPEAN PARLIAMENT

of 24 April 2007

on closing the accounts of the European Medicines Agency for the financial year 2005

(2008/522/EC)

THE EUROPEAN PARLIAMENT,

— having regard to the final annual accounts of the European Medicines Agency for the financial year

2005 (1),

— having regard to the Court of Auditors' report on the final annual accounts of the European Medicines

Agency for the financial year 2005, together with the Agency's replies (2),

— having regard to the Council's Recommendation of 27 February 2007 (5711/2007 — C6-0080/2007),

— having regard to the EC Treaty, and in particular Article 276 thereof,

— having regard to Council Regulation (EC, Euratom) No 1605/2002 of 25 June 2002 on the Financial
the European Communities (3), and in particular

Regulation applicable to the general budget of
Article 185 thereof,

— having regard to Regulation (EC) No 726/2004 of the European Parliament and of the Council of
31 March 2004 laying down Community procedures for the authorisation and supervision of medicinal
products for human and veterinary use and establishing a European Medicines Agency (4), and in
particular Article 68 thereof,

— having regard to Commission Regulation (EC, Euratom) No 2343/2002 of 19 November 2002 on the
framework Financial Regulation for the bodies referred to in Article 185 of Council Regulation (EC,
Euratom) No 1605/2002 (5), and in particular Article 94 thereof,

— having regard to Rule 71 of and Annex V to its Rules of Procedure,

— having regard to the Report of the Committee on Budgetary Control and the opinion of the Committee

on the Environment, Public Health and Food Safety (A6-0099/2007),

1. Notes that the final annual accounts of the European Medicines Agency for the financial years 2004 and

2005 are as follows:

Revenue and expenditure account for the financial years 2004 and 2005

Revenue

Fees relating to marketing authorisations

Commission subsidy including contributions received from the EE

Community subsidy for orphan medicines

(in EUR 1 000)

2005

2004

72 613

22 847

6 110

68 412

20 529

4 026

(1) OJ C 266, 31.10.2006, p. 4.
(2) OJ C 312, 19.12.2006, p. 12.
(3) OJ L 248, 16.9.2002, p. 1. Regulation as amended by Regulation (EC, Euratom) No 1995/2006 (OJ L 390, 30.12.2006,

p. 1).

(4) OJ L 136, 30.4.2004, p. 1. Regulation as amended by Regulation (EC) No 1901/2006 (OJ L 378, 27.12.2006, p. 1).
(5) OJ L 357, 31.12.2002, p. 72.

L 187/134

EN

Official Journal of the European Union

15.7.2008

(in EUR 1 000)

2005

2004

Contributions for Community programmes

Administrative revenue

Sundry revenue

Expenditure

Staff expenditure

Administrative expenditure

Operating expenditure

Depreciation

Other expenses

Operating result (c = a − b)

Financial result (e)

Economic outturn (f = c + e)

0

3 423

1 643

Total revenue (a)

106 636

40 057

17 022

41 999

5 333

104

Total expenditure (b)

104 515

2 121

2 257

4 378

0

1 973

1 473

96 413

34 333

11 224

38 573

3 650

280

88 060

8 353

1 160

9 513

Source: The Agency's data — This table summarises the data provided by the Agency in its annual accounts;

2.

3.

Approves closing the accounts of the European Medicines Agency for the financial year 2005;

Instructs its President to forward this Decision to the executive director of the European Medicines
Agency, the Council, the Commission and the Court of Auditors, and to arrange for its publication in the
Official Journal of the European Union (L series).

The President

Hans-Gert PÖTTERING

The Secretary-General

Harald RØMER